Dan Yrigoyen serves as Executive at Arch Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Dan Yrigoyen has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 30, 2021 involved receiving (via award) 150,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jul 30, 2021 | ARTH | $0 | Award | 150,000 | $N/A | Discretionary |
Dan Yrigoyen currently holds 150,000 shares of Arch Therapeutics, Inc. (ARTH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Dan Yrigoyen has been a net neutral trader of ARTH stock. They have purchased $0 and sold $0 worth of shares.
Dan Yrigoyen's most recent insider trade was on Jul 30, 2021, when they sold 150,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted